Graft

(redirected from delayed graft)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Graft

An informal term for bribery.

References in periodicals archive ?

Helsinki University Hospital, was to examine how serial urine NGAL (neutrophil gelatinase-associated lipocalin) concentrations change over time following kidney transplants and whether urine concentrations of NGAL can predict the onset of delayed graft function or prolonged delayed graft function.

Study Suggests Urine NGAL Biomarker May Help Predict Delayed Graft Function

1: Flow chart of peritoneal dialysis (PD) catheter-related outcomes from kidney transplant recipients treated with PD prior to transplantation; IGF: immediate graft function; DGF: delayed graft function; HD: hemodialysis.

Should peritoneal dialysis catheters be removed at the time of kidney transplantation?

QPI-1002 is being developed for the prevention of acute kidney injury (AKI) in patients undergoing major cardiovascular surgery, and for the prophylaxis of delayed graft function (DGF) in patients receiving deceased donor kidney transplants.

Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human

Secondary endpoints included: patient and graft survival up to 12 months after transplantation, duration of delayed graft function, length of stay in hospital, primary non-function of the transplanted kidney, serum creatinine and clearance after transplantation, acute rejection and calcineurin inhibitor toxicity.

Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice

Catalyst is focusing its product development efforts on drug candidates for hemophilia, non-hemophilic bleeding, and complement-driven diseases, including the prevention of delayed graft function and inflammation.

Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences

Both these contemporary studies confirm older reports by Sumrani and colleagues who showed that patients undergoing AN prior to re-transplantation had a higher %PRA and thus a higher incidence of delayed graft function in subsequent transplants.

Early but not late allograft nephrectomy reduces allosensitization after transplant failure

Secondary endpoints included: patient and graft survival up to 12 months after transplantation; duration of delayed graft function; length of stay in hospital; primary non-function of the transplanted kidney; serum creatinine and clearance after transplantation' acute rejection; and calcineurin inhibitor toxicity.

Machine preserved kidneys less likely to fail compared to cold storage, landmark randomized study finds

Based on these studies, we believe prevention of delayed graft function in renal transplantation and hemorrhagic shock associated with trauma, represent significant opportunities.

Inflazyme Pharmaceuticals Ltd. Letter to Shareholders

And importantly, we intend to initiate Phase 2 clinical testing of C1-INH in antibody mediated rejection and delayed graft function, as well as VP20621 for prevention of recurrence of C.

ViroPharma Provides 2011 Outlook

5,6] Delayed graft function (DGF), defined as the need for dialysis within the first week of transplantation,[sup.

Prediction of delayed graft function after renal transplantation

Quark Pharmaceuticals to develop drug candidate for prevention and treatment of delayed graft function in kidney transplantation

FDA Approves Quark IND for DGFi, an siRNA Therapeutic Based on Silence Therapeutics' Unique Proprietary Chemistry

Pharming Group NV, Leiden, The Netherlands, announced it has received orphan drug designations for recombinant human C1 inhibitor (rhC1INH) from the FDA for treatment of two separate disease indications - the prevention and/or treatment of Delayed Graft Function (DGF) after solid organ transplantation and the treatment of Capillary Leakage Syndrome (CLS).

Pharming receives orphan drug designations from FDA for rhC1INH use in treating DGF after organ transplantation